Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitor

Leung, AWY; Anantha, M; Dragowska, WH; Wehbe, M; Bally, MB

Leung, AWY (reprint author), BC Canc Res Ctr, Expt Therapeut 5 304, 675 West 10th Ave, Vancouver, BC V5Z 1L3, Canada.

JOURNAL OF CONTROLLED RELEASE, 2018; 286 (): 1

Abstract

CX-5461 is currently in Phase I/II clinical trials for advanced hematologic malignancies and triple negative or BRCA-deficient breast cancer. The comp......

Full Text Link